Sunday, August 13, 2023 4:51:37 PM
Real company SEC reporting on time with filings. No fluff, PPS grew with zero PRs. Impressive when every OTC stock is down in the sewers, sometimes between all the dirt one diamond sticks out.
All traders should be aware of BDPT by now. Money to be made on this 2023 run. Price is only $0.0036, still cheap for patented products worth tens of millions theoretically.
Organizational restructuring in full effect: clearing debt on the books, wholesale division, Livestock impact spin-off.
All traders should be aware of BDPT by now. Money to be made on this 2023 run. Price is only $0.0036, still cheap for patented products worth tens of millions theoretically.
Organizational restructuring in full effect: clearing debt on the books, wholesale division, Livestock impact spin-off.
Recent BDPT News
- BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery • GlobeNewswire Inc. • 05/20/2026 08:15:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:16:04 PM
- BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night • GlobeNewswire Inc. • 04/28/2026 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/14/2026 08:05:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 02:45:46 AM
- BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing • GlobeNewswire Inc. • 10/07/2025 03:48:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 07:16:01 PM
